Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Functional Hypothalamic Amenorrhea: Consequences Beyond the Menstrua…

Heart in Diabetes (HiD)

C. Shufelt

Cardiovascular Disease in the Very Old

Heart in Diabetes (HiD)

C. Ballantyne

The Case for Coronary Artery Calcium Scoring for Personalized Preven…

Todd Villines

Clinical Interventions in Atherosclerosis

Heart in Diabetes (HiD)

R. Chilton

Heart Failure Post Myocardial Infraction and Valvular Disease

Heart in Diabetes (HiD)

J. Butler

Impact of Cumulative Risk Factor Exposure on Incident Cardiovascular…

Heart in Diabetes (HiD)

M. J. Domanski

CAC Scoring in Assessment of Cardiovascular Risk

University Hospitals

G. Rao, I. Neeland

Best Practices for Treating Cardio-Renal-Metabolic Disease

Primary Care Education Consortium

L. Novak, L. Foster Smith

What Are the Metabolic Consequences of Insulin Resistance and What I…

Penn Medicine Heart and Vascular Center

D. Soffer

Getting Your Cholesterol to Goal: The Growing List of Therapies

The North American Thrombosis Forum (NATF)

N. Marston

New Targets and Upcoming Medications for Dyslipidemia

Heart in Diabetes (HiD)

N. E. Lepor

Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?

Penn Medicine Heart and Vascular Center

A. Bajaj

The PCSK9 - From Discovery to Translation & the Future of Therapeuti…

University of Louisville

M. Shapiro

Should I Use a Continuous Glucose Monitor, Even if I'm Healthy?

Integrative Medicine - Astrid Pujari

A. Pujari